'Game-changing' cancer service approved for rollout

A groundbreaking genetic testing technique, developed in Cambridge, has been approved for wider rollout, promising to make genetic testing accessible to more cancer patients. This innovative service will enable a greater number of individuals battling cancer to benefit from personalized treatment approaches based on their genetic profiles. The development represents a significant advancement in cancer care, potentially transforming how patients are diagnosed and treated by tailoring therapies to their specific genetic mutations. This expansion of genetic testing is anticipated to lead to more effective treatments and improved outcomes for cancer patients. The approval marks a pivotal moment for integrating advanced genetic science into mainstream medical practice.